Silo Pharma, Inc. SEC filings

Filings

1. 8-KSilo Pharma, Inc.SILO4d

   Silo Pharma acquires software assets

   • Entered into asset purchase agreement with Larry King
   • Issued 150,000 shares of common stock
   • Shares subject to 12-month lock-up period
2. 8-KSilo Pharma, Inc.SILOOct 2

   Silo Pharma acquires assets from Norsight

   • Entered asset purchase agreement with Norsight Consulting on 10/1/2026
   • Issued warrant for 300,000 shares at $1.51 exercise price
   • Warrant exercisable from 4/1/2027 to 9/30/2031
3. 8-KSilo Pharma, Inc.SILOAug 19

   Current report

4. 8-KSilo Pharma, Inc.SILOAug 17

   Current report

5. 10-QSilo Pharma, Inc.SILOAug 13

   Quarterly report

6. SCHEDULE 13G/ASilo Pharma, Inc.SILOAug 13

   Ownership stake disclosure by INTRACOASTAL CAPITAL, LLC (amended)

   INTRACOASTAL CAPITAL, LLC, filed by

7. EFFECTSilo Pharma, Inc.SILOAug 7

   Registration declared effective

8. 424B3Silo Pharma, Inc.SILOAug 6

   Securities offering

9. S-8Silo Pharma, Inc.SILOJul 31

   Employee stock plan registration

10. S-3Silo Pharma, Inc.SILOJul 24

    Securities offering

11. DSilo Pharma, Inc.SILOJul 14

    Private placement notice

12. SCHEDULE 13GSilo Pharma, Inc.SILOJul 8

    Ownership stake disclosure by AdvisorShares Trust

    AdvisorShares Trust, filed by

13. ARSSilo Pharma, Inc.SILOJun 30

    Annual report to shareholders

14. DEFA14ASilo Pharma, Inc.SILOJun 30

    Additional proxy materials

15. DEF 14ASilo Pharma, Inc.SILOJun 30

    Proxy statement

16. 8-KSilo Pharma, Inc.SILOJun 18

    Current report

17. PRE 14ASilo Pharma, Inc.SILOJun 18

    Preliminary proxy statement

18. 8-KSilo Pharma, Inc.SILOJun 3

    Current report

19. 8-KSilo Pharma, Inc.SILOJun 1

    Current report

20. 424B3Silo Pharma, Inc.SILOApr 16

    Securities offering

21. EFFECTSilo Pharma, Inc.SILOApr 16

    Registration declared effective

22. 424B3Silo Pharma, Inc.SILOApr 14

    Securities offering

23. POS AMSilo Pharma, Inc.SILOApr 14

    POS AM filing

24. EFFECTSilo Pharma, Inc.SILOApr 14

    Registration declared effective

25. POS AMSilo Pharma, Inc.SILOApr 10

    POS AM filing

26. 8-KSilo Pharma, Inc.SILOApr 2

    Current report

27. 10-KSilo Pharma, Inc.SILOMar 27

    Annual report

28. 8-KSilo Pharma, Inc.SILOFeb 23

    Current report

29. SCHEDULE 13G/ASilo Pharma, Inc.SILOFeb 17

    Ownership stake disclosure by Anson Funds Management LP (amended)

    Anson Funds Management LP, filed by

30. SCHEDULE 13G/ASilo Pharma, Inc.SILOFeb 13

    Ownership stake disclosure by INTRACOASTAL CAPITAL, LLC (amended)

    INTRACOASTAL CAPITAL, LLC, filed by

31. SCHEDULE 13G/ASilo Pharma, Inc.SILOFeb 13

    Ownership stake disclosure by SEG Opportunity Fund, LLC (amended)

    SEG Opportunity Fund, LLC, filed by

32. 8-KSilo Pharma, Inc.SILODec 29, 2025

    Current report

33. 4Silo Pharma, Inc.SILODec 16, 2025

    Eric Weisblum, insider filing for SILO

    Eric Weisblum, reporting

34. EFFECTSilo Pharma, Inc.SILONov 28, 2025

    Registration declared effective

35. 424B3Silo Pharma, Inc.SILONov 26, 2025

    Securities offering

36. 4Silo Pharma, Inc.SILONov 21, 2025

    Eric Weisblum, insider filing for SILO

    Eric Weisblum, reporting

37. 4Silo Pharma, Inc.SILONov 20, 2025

    Silo Pharma, Inc. - Insider ownership filing (4)

    • Insider ownership filing (4)
    • Reports beneficial ownership changes

    Eric Weisblum, reporting

38. SCHEDULE 13GSilo Pharma, Inc.SILONov 14, 2025

    Ownership stake disclosure by Anson Funds Management LP

    Anson Funds Management LP, filed by

39. 10-QSilo Pharma, Inc.SILONov 13, 2025

    Silo Pharma, Inc. (SILO) filed its Q3 2025 quarterly report (Form 10-Q), providing investors with an update on the company's financial performance and operational status.

40. SCHEDULE 13G/ASilo Pharma, Inc.SILONov 7, 2025

    Ownership stake disclosure by INTRACOASTAL CAPITAL, LLC (amended)

    INTRACOASTAL CAPITAL, LLC, filed by

Older filings on EDGAR